Data / Form D filings / Stealth Therapeutics, Inc.
Stealth Therapeutics, Inc.: Form D filings
Stealth Therapeutics, Inc., a biotechnology company in Madison, WI, filed 4 Form D notices with the SEC between 2012 and 2017. The latest, on August 10, 2017, reports $140,000 sold of a $200,000 offering to 5 investors.
Find out what Stealth Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 NOB HILL ROAD, SUITE 100, Madison, WI, 53713
- Phone
- (608) 217-2685
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Wisconsin
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1544817
The full lists. Form D filings in Wisconsin: 361 rows, $18.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2017 | New notice | $200,000 | $140,000 | $60,000 | 5 | Aug 8, 2017 | sec.gov |
| Jan 15, 2016 | New notice | $200,000 | $65,000 | $135,000 | 4 | Dec 31, 2015 | sec.gov |
| Aug 26, 2014 | New notice | $500,000 | $451,916 | $48,084 | 10 | Aug 22, 2014 | sec.gov |
| Mar 16, 2012 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth U. Johnson | Director | |
| Sam Adam | Executive Officer | |
| George U. Trutza | Director | |
| Bradley Glenn | Director | |
| Jake U. Orville | Director |
Every Form D from the week of Aug 7, 2017 · All recent filings in Wisconsin · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Stealth Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.